ArticleStem cells international2026

Integrative Multiomics Analysis Reveals a Cancer Stem Cell-Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma.

Yang Zi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.